vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and HCI Group, Inc. (HCI). Click either name above to swap in a different company.
HCI Group, Inc. is the larger business by last-quarter revenue ($246.2M vs $185.2M, roughly 1.3× AMICUS THERAPEUTICS, INC.). HCI Group, Inc. runs the higher net margin — 39.7% vs 0.9%, a 38.7% gap on every dollar of revenue. On growth, HCI Group, Inc. posted the faster year-over-year revenue change (52.1% vs 23.7%). HCI Group, Inc. produced more free cash flow last quarter ($440.8M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 9.2%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
HCI Equity Partners is a Washington, DC–based private equity firm with an additional office in Chicago, Illinois.
FOLD vs HCI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $246.2M |
| Net Profit | $1.7M | $97.7M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | 58.5% |
| Net Margin | 0.9% | 39.7% |
| Revenue YoY | 23.7% | 52.1% |
| Net Profit YoY | -88.5% | 3679.2% |
| EPS (diluted) | $0.00 | $7.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $246.2M | ||
| Q3 25 | $169.1M | $216.3M | ||
| Q2 25 | $154.7M | $221.9M | ||
| Q1 25 | $125.2M | $216.4M | ||
| Q4 24 | $149.7M | $161.9M | ||
| Q3 24 | $141.5M | $175.3M | ||
| Q2 24 | $126.7M | $206.2M | ||
| Q1 24 | $110.4M | $206.6M |
| Q4 25 | $1.7M | $97.7M | ||
| Q3 25 | $17.3M | $65.5M | ||
| Q2 25 | $-24.4M | $66.2M | ||
| Q1 25 | $-21.7M | $69.7M | ||
| Q4 24 | $14.7M | $2.6M | ||
| Q3 24 | $-6.7M | $5.7M | ||
| Q2 24 | $-15.7M | $54.1M | ||
| Q1 24 | $-48.4M | $47.6M |
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — | ||
| Q1 24 | 87.7% | — |
| Q4 25 | 8.6% | 58.5% | ||
| Q3 25 | 20.3% | 41.9% | ||
| Q2 25 | -6.1% | 42.5% | ||
| Q1 25 | -6.3% | 46.4% | ||
| Q4 24 | 10.7% | 3.6% | ||
| Q3 24 | 15.3% | 8.0% | ||
| Q2 24 | 11.8% | 36.9% | ||
| Q1 24 | -25.1% | 37.5% |
| Q4 25 | 0.9% | 39.7% | ||
| Q3 25 | 10.2% | 30.3% | ||
| Q2 25 | -15.8% | 29.8% | ||
| Q1 25 | -17.3% | 32.2% | ||
| Q4 24 | 9.8% | 1.6% | ||
| Q3 24 | -4.8% | 3.2% | ||
| Q2 24 | -12.4% | 26.2% | ||
| Q1 24 | -43.9% | 23.0% |
| Q4 25 | $0.00 | $7.29 | ||
| Q3 25 | $0.06 | $4.90 | ||
| Q2 25 | $-0.08 | $5.18 | ||
| Q1 25 | $-0.07 | $5.35 | ||
| Q4 24 | $0.05 | $0.32 | ||
| Q3 24 | $-0.02 | $0.52 | ||
| Q2 24 | $-0.05 | $4.24 | ||
| Q1 24 | $-0.16 | $3.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $1.2B |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $1.0B |
| Total Assets | $949.9M | $2.5B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $1.2B | ||
| Q3 25 | $263.8M | $987.9M | ||
| Q2 25 | $231.0M | $947.2M | ||
| Q1 25 | $250.6M | $754.5M | ||
| Q4 24 | $249.9M | $532.5M | ||
| Q3 24 | $249.8M | $518.8M | ||
| Q2 24 | $260.1M | $445.8M | ||
| Q1 24 | $239.6M | $655.4M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $1.0B | ||
| Q3 25 | $230.4M | $821.8M | ||
| Q2 25 | $204.3M | $758.6M | ||
| Q1 25 | $193.6M | $522.7M | ||
| Q4 24 | $194.0M | $453.3M | ||
| Q3 24 | $178.8M | $455.3M | ||
| Q2 24 | $132.5M | $447.3M | ||
| Q1 24 | $130.7M | $395.7M |
| Q4 25 | $949.9M | $2.5B | ||
| Q3 25 | $868.8M | $2.3B | ||
| Q2 25 | $815.3M | $2.4B | ||
| Q1 25 | $789.8M | $2.3B | ||
| Q4 24 | $785.0M | $2.2B | ||
| Q3 24 | $786.6M | $2.0B | ||
| Q2 24 | $749.5M | $1.9B | ||
| Q1 24 | $721.8M | $1.8B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $444.4M |
| Free Cash FlowOCF − Capex | $16.0M | $440.8M |
| FCF MarginFCF / Revenue | 8.6% | 179.0% |
| Capex IntensityCapex / Revenue | 0.2% | 1.5% |
| Cash ConversionOCF / Net Profit | 9.62× | 4.55× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $771.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $444.4M | ||
| Q3 25 | $35.7M | $26.7M | ||
| Q2 25 | $-26.5M | $145.0M | ||
| Q1 25 | $7.8M | $162.0M | ||
| Q4 24 | $-3.9M | $331.8M | ||
| Q3 24 | $-23.0M | $104.1M | ||
| Q2 24 | $22.7M | $-29.0M | ||
| Q1 24 | $-29.7M | $182.0M |
| Q4 25 | $16.0M | $440.8M | ||
| Q3 25 | $35.3M | $25.9M | ||
| Q2 25 | $-28.9M | $144.5M | ||
| Q1 25 | $7.5M | $160.3M | ||
| Q4 24 | $-4.2M | $327.8M | ||
| Q3 24 | $-23.3M | $103.2M | ||
| Q2 24 | $21.6M | $-30.1M | ||
| Q1 24 | $-31.5M | $181.0M |
| Q4 25 | 8.6% | 179.0% | ||
| Q3 25 | 20.9% | 12.0% | ||
| Q2 25 | -18.7% | 65.1% | ||
| Q1 25 | 6.0% | 74.1% | ||
| Q4 24 | -2.8% | 202.5% | ||
| Q3 24 | -16.5% | 58.9% | ||
| Q2 24 | 17.0% | -14.6% | ||
| Q1 24 | -28.5% | 87.6% |
| Q4 25 | 0.2% | 1.5% | ||
| Q3 25 | 0.2% | 0.4% | ||
| Q2 25 | 1.6% | 0.2% | ||
| Q1 25 | 0.2% | 0.8% | ||
| Q4 24 | 0.2% | 2.5% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.9% | 0.5% | ||
| Q1 24 | 1.6% | 0.5% |
| Q4 25 | 9.62× | 4.55× | ||
| Q3 25 | 2.06× | 0.41× | ||
| Q2 25 | — | 2.19× | ||
| Q1 25 | — | 2.32× | ||
| Q4 24 | -0.27× | 128.41× | ||
| Q3 24 | — | 18.33× | ||
| Q2 24 | — | -0.54× | ||
| Q1 24 | — | 3.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
HCI
| Insurance Operation | $218.3M | 89% |
| Reciprocal Exchange Operation | $27.0M | 11% |
